Study Stopped
PI has left University of Minnesota.
Fractional Laser Therapy and Dermabrasion for Scar Revision
A Comparison Evaluation of Fractional Laser Therapy an Dermabrasion for Scar Revision
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The goals of this study will be to compare the safety and efficacy of fractional photothermolysis (Fraxel) with dermabrasion when used for scar revision.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2010
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 2, 2011
CompletedFirst Posted
Study publicly available on registry
August 4, 2011
CompletedOctober 4, 2023
October 1, 2023
Same day
August 2, 2011
October 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
safety and efficacy of fractional photothermolysis
compare the safety and efficacy of fractional photothermolysis (Fraxel) with dermabrasion when used for scar revision.
Post Surgery
Study Arms (1)
laser and standard diamond fraise dermabrasion
NO INTERVENTIONlaser and standard diamond fraise dermabrasion
Interventions
standard dermabrasion, CO2 laser resurfacing
Eligibility Criteria
You may qualify if:
- post surgical or post traumatic scar on face or scalp
- age 18 or older
- able to read and comprehend English
- Willing to follow treatment schedule and post treatment care requirements
- signed informed consent form
- Fitzpatrick skin type I-III
You may not qualify if:
- known photosensitivity
- taken any medications known to induce photosensitivity in previous three months
- taken accutane within past 12 months
- pregnant or nursing
- currently on topical or oral antibiotics
- immunocompromised status
- skin type IV or greater
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Christophel, MD
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2011
First Posted
August 4, 2011
Study Start
March 1, 2010
Primary Completion
March 1, 2010
Study Completion
March 1, 2010
Last Updated
October 4, 2023
Record last verified: 2023-10